Amgen Inc (NASDAQ:AMGN)

255.55
Delayed Data
As of 6:40pm ET
 +1.53 / +0.60%
Today’s Change
177.05
Today|||52-Week Range
264.97
+6.01%
Year-to-Date
J&J Simponi Aria Gets FDA Nod for Pediatric Use in Arthritis
7:32am / Zacks.com - Paid Partner Content
Merck Enbrel biosimilar OK'd in Canada for four new uses
Sep 15 / Seeking Alpha - Paid Partner Content
The Extreme Risks of Trading Your Own Retirement Assets - September 30, 2020
Sep 30 / Zacks.com - Paid Partner Content
Dividends And Reasonable Price Appreciation: Introducing The 'DARPA' Portfolio
Sep 13 / Seeking Alpha - Paid Partner Content
Better Buy: Gilead Sciences vs. Amgen
Sep 29 / MotleyFool.com - Paid Partner Content
Retire Rich: Buy Low And Sell High Consistently
Sep 12 / Seeking Alpha - Paid Partner Content
5 Reasons to Invest in Dividend-Paying Stocks for Retirement
Sep 28 / MotleyFool.com - Paid Partner Content
Amgen (AMGN) Investor Presentation - Slideshow
Sep 11 / Seeking Alpha - Paid Partner Content
4 Reasons AbbVie Is More Attractive Than You Think
Sep 26 / MotleyFool.com - Paid Partner Content
Seeking Alpha Catalyst Watch
Sep 11 / Seeking Alpha - Paid Partner Content
5 Buffett-Munger Stocks With High Dividend Yields
Sep 25 / GuruFocus News - Paid Partner Content
Why Stocks Could Be Ready To Rally
Sep 11 / Seeking Alpha - Paid Partner Content
Simple Secrets Anyone Can Use to Reach Early Retirement - September 25, 2020
Sep 25 / Zacks.com - Paid Partner Content
Amgen Inc. (AMGN) Presents at Citi 15th Annual Biopharma Conference (Transcript)
Sep 10 / Seeking Alpha - Paid Partner Content
How Trading Your Own Retirement Can Fleece Your Financial Future - September 22, 2020
Sep 22 / Zacks.com - Paid Partner Content
Amgen: Massive Pharmaceutical Strength
Sep 09 / Seeking Alpha - Paid Partner Content
Trump's Pep Talk Raises Vaccine Hopes: 4 Stocks to Watch
Sep 21 / Zacks.com - Paid Partner Content
There Is No Alternative
Sep 09 / Seeking Alpha - Paid Partner Content
Dow Jones Changes Could Impact Investor Portfolios
Sep 21 / MotleyFool.com - Paid Partner Content
Nicholas Ward's Dividend Growth Portfolio: August 2020 Review
Sep 07 / Seeking Alpha - Paid Partner Content
Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)?
Sep 21 / Zacks.com - Paid Partner Content
Amgen Still A Buy After Joining The Dow
Sep 05 / Seeking Alpha - Paid Partner Content
Amgen's sotorasib shows encouraging clinical benefit in KRAS G12C-mutant tumors
Sep 21 / Seeking Alpha - Paid Partner Content
Stocks stage late comeback but still end day lower
Sep 04 / CNN.com - Paid Partner Content
The 5 Undervalued Blue Chip High Dividend Growth Stocks You Need To Buy Now
Sep 20 / Seeking Alpha - Paid Partner Content
The Sell-Off Accelerates: What To Do Now
Sep 03 / Seeking Alpha - Paid Partner Content
Sector Watch: More oncology events as cancer ETF breaks out
Sep 20 / Seeking Alpha - Paid Partner Content
Akebia down big after vadadustat misses safety endpoints in late-stage studies in CKD anemia
Sep 03 / Seeking Alpha - Paid Partner Content
Amgen: Growing At A Reasonable Price
Sep 20 / Seeking Alpha - Paid Partner Content
Amarin's Vascepa Data, And Other News: The Good, Bad And Ugly Of Biopharma
Sep 03 / Seeking Alpha - Paid Partner Content
Where Will Amgen Be in 1 Year?
Sep 19 / MotleyFool.com - Paid Partner Content
Illusion, Perception And Reality: Stock Splits And Index Inclusions
Sep 02 / Seeking Alpha - Paid Partner Content
Seeking Alpha Catalyst Watch
Sep 18 / Seeking Alpha - Paid Partner Content
V&M Breakouts: Top Growth And Dividend Mega-Cap Stocks For September 2020
Sep 01 / Seeking Alpha - Paid Partner Content
Lilly, Amgen Ink Manufacturing Deal for Coronavirus Antibodies
Sep 18 / Zacks.com - Paid Partner Content
Mid-stage platform study underway assessing treatments for critically ill COVID-19 patients
Sep 01 / Seeking Alpha - Paid Partner Content
European advisory group back Pfizer's Neulasta biosimilar
Sep 18 / Seeking Alpha - Paid Partner Content
Back To School: 8 Hot All Weather Dividend Buys, And 3 We Might Sell
Sep 01 / Seeking Alpha - Paid Partner Content
Lilly teams up with Amgen to scale-up production of COVID-19 antibody therapies
Sep 17 / Seeking Alpha - Paid Partner Content
AbbVie under pressure on House Committee subpoena in price-fixing probe
Sep 01 / Seeking Alpha - Paid Partner Content
Amgen Inc. (AMGN) Management Presents at Morgan Stanley's 18th Annual Virtual Global Healthcare Conference (Transcript)
Sep 16 / Seeking Alpha - Paid Partner Content
AbbVie under pressure on House Committee subpoena in drug pricing probe
Sep 01 / Seeking Alpha - Paid Partner Content